Location History:
- Pittsburgh, PA (US) (2003)
- Sewickley, PA (US) (2008 - 2012)
- Wexford, PA (US) (2016 - 2018)
Company Filing History:
Years Active: 2003-2024
Title: The Innovative Contributions of Joseph M. Ahearn
Introduction
Joseph M. Ahearn, an accomplished inventor based in Sewickley, Pennsylvania, is recognized for his significant contributions to the fields of diagnostics and biomedical research. With a portfolio comprising 12 patents, Ahearn has focused on advancing medical technology, particularly in the diagnosis and monitoring of autoimmune disorders such as lupus.
Latest Patents
Among his recent inventions is a patent titled "Methods and systems using C4 gene copy number and cell-bound complement activation products for identification of lupus and pre-lupus." This innovative approach combines cell-bound complement activation product profiling with the determination of C4 gene copy number to serve as effective biomarkers for lupus diagnosis and monitoring. Another notable patent is "Cell-bound complement activation product assays as companion diagnostics for antibody-based drugs," which provides methods and systems for determining a patient's likelihood of benefiting from antibody-based therapies. This work emphasizes the importance of cell-bound complement activation products associated with B lymphocytes as diagnostic biomarkers.
Career Highlights
Joseph Ahearn has collaborated with esteemed institutions throughout his career. He has contributed to research at the University of Pittsburgh and the Allegheny Singer Research Institute, where he has been involved in pioneering studies that blur the lines between various medical disciplines. His work has positioned him as a key figure in the development of innovative medical diagnostics.
Collaborations
In addition to his institutional affiliations, Ahearn has worked alongside respected colleagues, including Susan M. Manzi and Chau-Ching Liu. These collaborations have further enhanced the efficacy and impact of his research, fostering innovation in patient diagnostics and therapeutic strategies.
Conclusion
Joseph M. Ahearn exemplifies dedication and innovation within the biomedical field. His extensive patent portfolio and collaborative efforts highlight his commitment to advancing healthcare technologies. As he continues to pursue groundbreaking research, Ahearn remains a prominent inventor pushing the boundaries of what is possible in medical diagnostics.